Elevated blood levels of the enzyme PHGDH may be an early indicator of Alzheimer’s disease (AD), according to a new study published in Cell Metabolism.
Prenatal exposure to topiramate, valproate and several dual therapies is associated with increased risk of autism spectrum disorder and/or intellectual disability.